Migraine medications
Migraine medicines fall into two groups: acute medicines taken for an attack, and preventive medicines taken to reduce attacks. ICHD-3, the international headache classification, gives each class of acute medicine a limit of 10 or 15 days a month. ICHD-3 does not name gepants or lasmiditan; its subtype 8.2.8 sets 10 days for other acute medicines.
On this page
Acute and preventive medicines
- Acute medicines are taken for an attack. Their trials usually measure the result 2 hours after the dose.
- Preventive medicines are taken to reduce attacks. Daily preventive medicine does not count toward the limits below.
Rimegepant belongs to both groups: its US label covers acute treatment and prevention of episodic migraine.
A 2021 American Headache Society statement, as reported by MDedge, says to offer prevention at 6 or more headache days a month, or 3 to 4 days with some to severe disability. NICE names propranolol, topiramate or amitriptyline for prevention and advises discussing benefits and risks with each person.
Classes of acute medicine
| Class | Pages | Days per month, for more than 3 months | ICHD-3 |
|---|---|---|---|
| Triptans | sumatriptan, rizatriptan, zolmitriptan, eletriptan | 10 or more | 8.2.2 |
| Non-opioid painkillers | ibuprofen, naproxen, acetaminophen, aspirin | 15 or more | 8.2.3 |
| Combination painkillers | Excedrin | 10 or more | 8.2.5 |
| Ergotamines | Not covered here | 10 or more | 8.2.1 |
| Opioids | Not covered here | 10 or more | 8.2.4 |
| Gepants | rimegepant, ubrogepant | Not named; general rule 10 or more | 8.2.8 |
| Ditans | lasmiditan | Not named; general rule 10 or more | 8.2.8 |
What guidelines name
Guidelines are written for prescribers. The choice depends on the person and is made with a doctor or pharmacist.
- NICE CG150 (UK). An oral triptan with an NSAID or with paracetamol. For people who prefer one medicine: an oral triptan, an NSAID, aspirin or paracetamol. An anti-emetic may be added. NICE says not to offer ergots or opioids for acute treatment, and not to offer aspirin to under-16s.
- American Headache Society, 2021, as reported by MDedge. NSAIDs, non-opioid painkillers, acetaminophen or caffeine-containing combinations for mild to moderate attacks. Triptans, gepants or ditans for moderate or severe attacks. A non-oral form when attacks often bring severe nausea or vomiting.
Monthly limits
ICHD-3 limits count days, not doses, and apply when overuse lasts more than 3 months with headache on 15 or more days a month. All non-opioid painkillers count as one class. Several types, none over its own limit, count against 10 days in total. Other acute medicines fall under the general subtype 8.2.8, at 10 or more days a month for more than 3 months. It does not name gepants or lasmiditan.
Some US labels use 10 days where ICHD-3 uses 15. The ibuprofen migraine label warns about use on 10 or more days a month.
One month over a limit is not a diagnosis. See medication-overuse headache for the criteria and the position on gepants and lasmiditan, and use the medication days counter for your own count.
Recording a medicine
Write down the day, time, medicine and form, then the pain 2 hours later. Trials report two outcomes: no pain at all, and pain reduced to mild or none. A printable diary has a column for this.
Sources
- ICHD-3, 8.2 Medication-overuse headache
- ICHD-3, 8.2.1 Ergotamine-overuse headache
- ICHD-3, 8.2.2 Triptan-overuse headache
- ICHD-3, 8.2.3 Non-opioid analgesic-overuse headache
- ICHD-3, 8.2.4 Opioid-overuse headache
- ICHD-3, 8.2.5 Combination-analgesic-overuse headache
- ICHD-3, 8.2.6 Medication-overuse headache attributed to multiple drug classes not individually overused
- ICHD-3, 8.2.8 Medication-overuse headache attributed to other medication
- NICE CG150. Headaches in over 12s: diagnosis and management. Recommendations
- MDedge: Updated consensus statement assesses new migraine treatments (American Headache Society, 2021)
- Nurtec ODT (rimegepant) prescribing information, revised 4/2026
- Imitrex (sumatriptan) tablets prescribing information, revised 12/2025
- Motrin IB Migraine (ibuprofen) label, DailyMed, December 2025
Checked against these sources on 2 November 2026. How this page is written and checked